Interleukin-2 receptor antibody does not reduce rejection risk in low immunological risk or tacrolimus-treated intermediate immunological risk renal transplant recipients

Artificial intelligence (AI) promises significant advancements in nephrology. While current use of AI in clinical nephrology practice is limited, there is scope for application in transplant…

Background: The proportion of dialysis patients performing PD in Australia is decreasing over time.1 Understanding the trends in population, the rates and causes of peritonitis and haemodialysis (HD)…